Renal sympathetic denervation for treatment of drug-resistant hypertension one-year results from the symplicity HTN-2 randomized, controlled trial

Murray D Esler; Henry Krum; Markus Peter Schlaich; Roland E Schmieder; Michael Bohm; Paul Sobotka

doi:10.1161/CIRCULATIONAHA.112.130880

Renal sympathetic denervation for treatment of drug-resistant hypertension one-year results from the symplicity HTN-2 randomized, controlled trial

Murray D Esler, Henry Krum, Markus Peter Schlaich, Roland E Schmieder, Michael Bohm, Paul Sobotka

Epidemiology and Preventive Medicine Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

404 Citations (Scopus)

Abstract

Control patients who crossed over to renal denervation with the Symplicity system had a significant drop in blood pressure similar to that observed in patients receiving immediate denervation. Renal denervation provides safe and sustained reduction of blood pressure to 1 year.

Original language	English
Pages (from-to)	2976 - 2982
Number of pages	7
Journal	Circulation
Volume	126
Issue number	25
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.112.130880
Publication status	Published - 2012

Access to Document

10.1161/CIRCULATIONAHA.112.130880

Cite this

@article{997e023758624883a8c6bb2801226082,

title = "Renal sympathetic denervation for treatment of drug-resistant hypertension one-year results from the symplicity HTN-2 randomized, controlled trial",

abstract = "Control patients who crossed over to renal denervation with the Symplicity system had a significant drop in blood pressure similar to that observed in patients receiving immediate denervation. Renal denervation provides safe and sustained reduction of blood pressure to 1 year.",

author = "Esler, {Murray D} and Henry Krum and Schlaich, {Markus Peter} and Schmieder, {Roland E} and Michael Bohm and Paul Sobotka",

year = "2012",

doi = "10.1161/CIRCULATIONAHA.112.130880",

language = "English",

volume = "126",

pages = "2976 -- 2982",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams & Wilkins",

number = "25",

}

TY - JOUR

T1 - Renal sympathetic denervation for treatment of drug-resistant hypertension one-year results from the symplicity HTN-2 randomized, controlled trial

AU - Esler, Murray D

AU - Krum, Henry

AU - Schlaich, Markus Peter

AU - Schmieder, Roland E

AU - Bohm, Michael

AU - Sobotka, Paul

PY - 2012

Y1 - 2012

N2 - Control patients who crossed over to renal denervation with the Symplicity system had a significant drop in blood pressure similar to that observed in patients receiving immediate denervation. Renal denervation provides safe and sustained reduction of blood pressure to 1 year.

AB - Control patients who crossed over to renal denervation with the Symplicity system had a significant drop in blood pressure similar to that observed in patients receiving immediate denervation. Renal denervation provides safe and sustained reduction of blood pressure to 1 year.

UR - http://www.ncbi.nlm.nih.gov/pubmed/?term=Renal+sympathetic+denervation+for+treatment+of+drug-resistant+hypertension+one-year+results+from+the+symplicl

U2 - 10.1161/CIRCULATIONAHA.112.130880

DO - 10.1161/CIRCULATIONAHA.112.130880

M3 - Article

SN - 0009-7322

VL - 126

SP - 2976

EP - 2982

JO - Circulation

JF - Circulation

IS - 25

ER -

Renal sympathetic denervation for treatment of drug-resistant hypertension one-year results from the symplicity HTN-2 randomized, controlled trial

Abstract

Access to Document

Other files and links

Cite this